FDA approves new AIDS treatment from Merck
Merck had created a new treatment for AIDS which is the first in a new class of drugs aimed at preventing replication of the virus. Recently, that treatment has been approved by U.S. regulators, the FDA. This new treatmnet from Merck is the first in a new class of HIV treatment options that are known as integrase inhibitors. These new kind of treatment options work by blocking insertion of HIV genetic material into human DNA in order to completely prevent the creation of copies of the virus in this way.
Drug-resistant patient population has the highest unmet medical need as being felt and mentioned by Merck, which is also studying the drug in previously untreated patients. Resistance is a major problem as the human immunodeficiency virus that causes AIDS can mutate on its own especially in case of those kind of patients that fail to rigorously follow the often complicated drug regimes as required for the treatment of the virus.
0 Comments:
Post a Comment
<< Home